NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/06/2026
Back to search
Official data from USPTO
RHEUMAGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RHEUMAGEN
ST13
US500000090372395Class
42, 44
Filing
90372395
Registration
8096117
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
49
Latest update
01/06/2026
Trademark type
Word
Nice classes
42, 44
Filing date
12/10/2020
Registration date
01/06/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/06/2026
Last transaction
01/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/06/2020
First use in commerce
05/06/2020
Drawing code
4
Owner type
03
Owner location
Aurora, CO, US
Examiner
PERRY, KIMBERLY B
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
RHEUMAGEN, INC.
RheumaGen, LLC
Representatives
Jenny T. Slocum Dickinson Wright, PLLC
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Product development for others in the field of pharmaceutical preparations and therapeutic treatmentsincluding for gene therapy and gene editing; scientific consulting and research services relating to pharmaceuticals and therapeutic treatments; research and development of new productsincluding for gene therapy and gene editing; Providing medical and scientific research information in the fields of pharmaceuticalsbiochemistrybiotechnologyclinical trials; drug discovery services; Providing medical research information in the fields of diagnosticprophylactictherapeutic properties of pharmaceuticals
Class 44
Providing medical information in the fields of diagnosticprophylactictherapeutic properties of pharmaceuticals; online medical information services
Publications
History of USPTO decisions and trademark events.
49 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/06/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/12/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/12/2025
DOCK
ASSIGNED TO EXAMINER
12/11/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/28/2025
IUAF
USE AMENDMENT FILED
02/21/2025
EISU
TEAS STATEMENT OF USE RECEIVED
02/21/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/13/2024
EX5G
SOU EXTENSION 5 GRANTED
08/13/2024
EXT5
SOU EXTENSION 5 FILED
08/13/2024
EEXT
SOU TEAS EXTENSION RECEIVED
08/13/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/21/2024
EX4G
SOU EXTENSION 4 GRANTED
02/20/2024
EXT4
SOU EXTENSION 4 FILED
02/20/2024
EEXT
SOU TEAS EXTENSION RECEIVED
02/20/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/03/2023
EX3G
SOU EXTENSION 3 GRANTED
10/02/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/02/2023
NREV
NOTICE OF REVIVAL - E-MAILED
09/05/2023
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
09/05/2023
DOCK
ASSIGNED TO EXAMINER
09/05/2023
PETG
PETITION TO REVIVE-GRANTED
09/05/2023
PROA
TEAS PETITION TO REVIVE RECEIVED
09/05/2023
EXT3
SOU EXTENSION 3 FILED
08/22/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/22/2023
EX2G
SOU EXTENSION 2 GRANTED
02/20/2023
EXT2
SOU EXTENSION 2 FILED
02/20/2023
EEXT
SOU TEAS EXTENSION RECEIVED
02/20/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/01/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/24/2022
EX1G
SOU EXTENSION 1 GRANTED
08/22/2022
EXT1
SOU EXTENSION 1 FILED
08/22/2022
EEXT
SOU TEAS EXTENSION RECEIVED
08/22/2022
DOCK
ASSIGNED TO EXAMINER
07/12/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/22/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/28/2021
PUBO
PUBLISHED FOR OPPOSITION
12/28/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/22/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/20/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/20/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/20/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/09/2021
GNRT
NON-FINAL ACTION E-MAILED
06/09/2021
CNRT
NON-FINAL ACTION WRITTEN
06/09/2021
DOCK
ASSIGNED TO EXAMINER
06/02/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/17/2021
NWAP
NEW APPLICATION ENTERED
12/14/2020
Continuous trademark protection
Get notified about every new filing that threatens RHEUMAGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.